ストックスクリーナーアプリを入手
21.79
7.39%
-1.74
プレマーケット:
21.91
0.12
+0.55%
前日終値:
$23.53
開ける：
$23.05
24時間の取引高:
18.28M
Relative Volume:
1.41
時価総額：
$4.76B
収益：
$1.24B
当期純損益:
$101.26M
株価収益率:
-128.18
EPS:
-0.17
ネットキャッシュフロー:
$149.62M
1週間 パフォーマンス:
-21.05%
1か月 パフォーマンス:
-1.63%
6か月 パフォーマンス:
+17.15%
1年 パフォーマンス:
+181.52%
1日の値動き範囲:
$21.44
$23.12
1週間の範囲:
$19.15
$25.45
52週間の値動き範囲:
$7.505
$30.44
Hims Hers Health Inc Stock (HIMS) Company Profile
名前
Hims Hers Health Inc
電話
415-851-0195
住所
2269 CHESTNUT ST, SAN FRANCISCO
HIMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| HIMS | 21.79 | 4.76B | 1.24B | 101.26M | 149.62M | -0.17 |
| PG | 170.89 | 401.37B | 83.91B | 14.32B | 15.85B | 6.16 |
| UL | 57.55 | 143.21B | 64.93B | 7.15B | 0 | 3.4285 |
| CL | 93.91 | 76.48B | 20.11B | 2.87B | 3.40B | 1.92 |
| KVUE | 23.78 | 45.59B | 15.46B | 1.06B | 1.40B | 0.496 |
| KMB | 136.37 | 45.48B | 20.10B | 2.61B | 2.90B | 5.20 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-28 | 開始されました | TD Cowen | Outperform |
| 2023-04-11 | 開始されました | Robert W. Baird | Neutral |
| 2023-02-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-11-08 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-07-15 | 開始されました | SVB Leerink | Underperform |
| 2022-04-14 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Outperform |
| 2022-03-10 | 開始されました | Deutsche Bank | Hold |
| 2021-12-02 | 開始されました | Jefferies | Hold |
| 2021-11-11 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 開始されました | BofA Securities | Neutral |
| 2021-05-20 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 開始されました | Truist | Hold |
| 2021-03-09 | 開始されました | Credit Suisse | Neutral |
| 2021-03-02 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | 開始されました | Citigroup | Neutral |
| 2021-02-12 | 開始されました | Piper Sandler | Neutral |
| 2021-02-08 | 開始されました | Tigress Financial | Buy |
すべてを表示
Hims Hers Health Inc (HIMS) 最新ニュース
Principal Financial Group Inc. Has $5.35 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Amazon's push into telehealth knocks shares of Hims & Hers - MSN
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? - AOL
Amazon Sets Sights on Both Hims & Hers and Temu. Is This a Golden Opportunity to Buy the Stock? - The Motley Fool
Hims & Hers stock falls as Amazon launches Telehealth offering - MSN
Will Amazon Bury Hims Stock or Should You Buy the Dip? - Yahoo Finance
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead (NYSE:HIMS) - Seeking Alpha
TD Cowen reaffirms Buy rating on Hims and Hers stock, highlights FDA case impact - Investing.com
Connor Clark & Lunn Investment Management Ltd. Lowers Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Stock Gains 31.1% Since Q3 Earnings: What's Next? - MSN
Hims & Hers health chief commercial officer sells $165,000 in stock - Investing.com
hims & hers COO Melissa Baird sells shares worth $1.24 million - Investing.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownShould You Sell? - MarketBeat
Hims & Hers Health Inc (HIMS) Trading 8.64% Higher on Nov 19 - GuruFocus.com
Hims & Hers stock (HIMS) drops 24% after Amazon telehealth announcement—here's why - InvestorsObserver
Hims & Hers Stock Climbs After Former Regulator Autor Joins Board - Marketscreener.com
Unpacking the Latest Options Trading Trends in Hims & Hers Health - Benzinga
Hims & Hers Stock Tumbles Amid Amazon Telehealth Push - AskTraders
Price Over Earnings Overview: Hims & Hers Health - Benzinga
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions - BioSpace
Hims & Hers Bolsters Leadership with Former FDA Commissioner, Quality Expert | HIMS Stock News - StockTitan
Royce & Associates LP Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory - Insider Monkey
Should You Buy Hims & Hers Stock On The Dip? - Barchart
Amazon.com Inc (AMZN-Q) QuotePress Release - The Globe and Mail
Hims & Hers Stock Is Down 30% This Week: Here's What Happened - AOL
Insider Sale: Director David Wells Sells 40,000 Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Should You Buy Hims & Hers Stock on the Dip? - Nasdaq
Hims & Hers: Revolutionizing Telehealth And Captivating InvestorsHere's Why You Should Buy - Seeking Alpha
Hims & Hers Health: The Amazon Curse Is Being Overstated (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Insider Trades Send A Signal - Benzinga
Hims Drops Most Ever as Amazon Enters Hair-Loss Drug Market - The Business of Fashion
Hims & Hers Shares Drop Following Amazon's Expansion into Telehe - GuruFocus.com
Hims & Hers Shares Drop Following Amazon's Expansion into Telehealth - Yahoo Finance
State of New Jersey Common Pension Fund D Has $2.28 Million Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Director Anja Manuel Acquires 5,000 Shares of Hims & Hers Health Inc (HIMS) - GuruFocus.com
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments - The Wall Street Journal
Hims & hers director Manuel Anja acquires $132,259 in stock - Investing.com
Hims & Hers health CFO sells shares worth $4.28 million - Investing.com
Hims & Hers director David Wells sells $1.2 million in stock - Investing.com
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare - MSN
Notable Thursday Option Activity: HIMS, PAG, SNOW - Nasdaq
BofA cuts Hims & Hers rating on Amazon market entry - Investing.com
BofA cuts Hims & Hers rating on Amazon market entry By Investing.com - Investing.com Australia
Hims & Hers Stock’s Retail Army Brushes Off Amazon Medical One’s Rival Service Even As Citi Sees Threat - MSN
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs - Fast Company
Amazon to Sell Cheap Hair-Loss Drugs. It’s a Big Threat for Hims & Hers Stock. - Barron's
Hims & Hers cut to underperform by BoA over Amazon competition (NYSE:HIMS) - Seeking Alpha
Amazon launches lifestyle drug service as challenge to Hims & Hers - Yahoo Finance
Amazon Challenges Telehealth With New Affordable Service - Finimize
Hims Hers Health Inc (HIMS) 財務データ
収益
当期純利益
現金流量
EPS
0.71%
2.23%
大文字化:
|
ボリューム (24 時間):